Midway Capital Research & Management Makes New $2.86 Million Investment in Synopsys, Inc. $SNPS

Midway Capital Research & Management purchased a new position in shares of Synopsys, Inc. (NASDAQ:SNPS) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 6,082 shares of the semiconductor company’s stock, valued at approximately $2,857,000. Synopsys makes up 2.8% of Midway Capital Research & Management’s investment portfolio, making the stock its 11th biggest position.

A number of other hedge funds also recently bought and sold shares of the business. Employees Provident Fund Board acquired a new stake in shares of Synopsys in the fourth quarter valued at approximately $302,661,000. S Harris Financial Group LLC purchased a new stake in Synopsys in the 4th quarter valued at about $200,000. EJMK Ventures LLC purchased a new stake in shares of Synopsys in the 4th quarter valued at approximately $302,000. Tulsa Wealth Advisors INC purchased a new stake in Synopsys in the fourth quarter valued at approximately $456,000. Finally, Ovata Capital Management Ltd purchased a new stake in shares of Synopsys in the 4th quarter valued at $1,221,000. Institutional investors and hedge funds own 85.47% of the company’s stock.

Insider Buying and Selling at Synopsys

In related news, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the sale, the chief financial officer directly owned 14,358 shares in the company, valued at $6,461,387.16. The trade was a 19.12% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the transaction, the chief executive officer owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 0.56% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on SNPS shares. HSBC lowered shares of Synopsys from a “buy” rating to a “hold” rating and set a $455.00 target price on the stock. in a report on Friday, February 20th. Morgan Stanley boosted their target price on Synopsys from $480.00 to $525.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 28th. Stifel Nicolaus boosted their price target on shares of Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Bank of America increased their price objective on Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Finally, BNP Paribas Exane raised their price target on Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a report on Thursday, May 28th. Nine investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $563.81.

Synopsys Stock Performance

NASDAQ:SNPS opened at $455.51 on Friday. The stock has a fifty day moving average price of $479.14 and a two-hundred day moving average price of $462.05. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. The stock has a market capitalization of $87.22 billion, a price-to-earnings ratio of 105.44, a PEG ratio of 2.68 and a beta of 1.22. Synopsys, Inc. has a 1 year low of $376.18 and a 1 year high of $651.73.

Synopsys (NASDAQ:SNPS) last released its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The firm had revenue of $2.28 billion for the quarter, compared to the consensus estimate of $2.25 billion. During the same quarter in the previous year, the firm earned $3.67 earnings per share. The firm’s revenue was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, sell-side analysts anticipate that Synopsys, Inc. will post 10.65 earnings per share for the current fiscal year.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.